Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

9.48
-0.2100-2.17%
Post-market: 9.800.3200+3.38%19:34 EDT
Volume:453.45K
Turnover:4.35M
Market Cap:435.10M
PE:-4.00
High:9.92
Open:9.78
Low:9.48
Close:9.69
52wk High:25.96
52wk Low:4.42
Shares:45.90M
Float Shares:37.58M
Volume Ratio:0.81
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3710
EPS(LYR):-2.2432
ROE:-28.21%
ROA:-18.47%
PB:1.16
PE(LYR):-4.23

Loading ...

Company Profile

Company Name:
BioAge Labs Inc.
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
61
Office Location:
5885 Hollis Street,Suite 370,EmeryVille,California,United States
Zip Code:
94608
Fax:
- -
Introduction:
BioAge Labs, Inc. was incorporated in Delaware on April 1, 2015. It is a clinical-stage biopharmaceutical company developing therapeutic candidates for metabolic diseases such as obesity by targeting the biology of human aging. Its technology platform and differentiated human datasets enable the identification of promising targets based on insights into the molecular changes that drive aging. Its primary focus is metabolic disease, one of the largest global healthcare challenges.

Directors

Name
Position
Kristen Fortney
Chief Executive Officer, President and Director
Eric Morgen
Chief Operating Officer and Director
Jean Pierre Garnier
Chair of the Board
James Healy
Director
Michael Davidson
Director
Patrick Enright
Director
Rekha Hemrajani
Director
Vijay Pande
Director

Shareholders

Name
Position
Kristen Fortney
Chief Executive Officer, President and Director
Eric Morgen
Chief Operating Officer and Director
Dov Goldstein
Chief Financial Officer
Paul Rubin
Chief Medical Officer